Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424
about
Role of short-acting nitroglycerin in the management of ischemic heart diseaseDifferent treatment options in chronic coronary artery disease: when is it the time for medical treatment, percutaneous coronary intervention or aortocoronary bypass surgery?The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infAchievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke).A randomized, double-blind, placebo-controlled, crossover, dose-ranging multicenter study to determine the effect of sublingual nitroglycerin spray on exercise capacity in patients with chronic stable anginaRecurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options.Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trialNitrates as an integral part of optimal medical therapy and cardiac rehabilitation for stable angina: review of current concepts and therapeutics.Stable angina pectoris.Role of Fractional-Flow Reserve in Guiding Percutaneous Revascularization in Stable Coronary Artery Disease.Reexamining the Efficacy and Value of Percutaneous Coronary Intervention for Patients With Stable Ischemic Heart Disease.Percutaneous coronary revascularization in coronary artery disease: lessons from a single center experience.Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug EEffect of baseline exercise capacity on outcomes in patients with stable coronary heart disease (a post hoc analysis of the clinical outcomes utilizing revascularization and aggressive drug evaluation trial).Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society
P2860
Q26796452-472350CF-0674-4827-B56C-A4651923C0DCQ30319078-6CBD419B-5614-43A8-8673-6CDA53ED4681Q33696402-41613E43-4882-4100-B262-C47F08C9E059Q34364029-82C8CADE-98B2-4357-ADD0-6684DB1DFBE7Q35927515-8ABCF833-B457-4E84-8C6A-A6B32E9EB9D7Q37140881-D5E298CA-2862-4F2B-ADE5-3418C615F273Q37521237-2687427D-DE9D-4948-8CD0-93BF278E8DDFQ38004987-42C6B7C9-9A50-4A75-8AB4-1D1714DD78F9Q38212580-378BF85C-1226-4066-9988-7BB17E80E976Q38552516-B25ABE4E-F969-4360-AEEB-DD3E08B84F6EQ38845089-8717A541-7F35-4F6A-A2EC-28483E0E5090Q39249132-7CAE0E1B-BACE-413D-A025-D4C20BAB0205Q42602556-961DE29B-B9A7-461D-90E2-FA3DF329DFCBQ42632315-8BE561A7-1D1F-4C6A-89D4-F5ADC5EAF083Q57339258-D01B9EAC-CDD8-4C28-B3DC-63E7A528C92A
P2860
Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Design and rationale of the Cl ...... rative Studies Program no. 424
@ast
Design and rationale of the Cl ...... rative Studies Program no. 424
@en
Design and rationale of the Cl ...... rative Studies Program no. 424
@nl
type
label
Design and rationale of the Cl ...... rative Studies Program no. 424
@ast
Design and rationale of the Cl ...... rative Studies Program no. 424
@en
Design and rationale of the Cl ...... rative Studies Program no. 424
@nl
prefLabel
Design and rationale of the Cl ...... rative Studies Program no. 424
@ast
Design and rationale of the Cl ...... rative Studies Program no. 424
@en
Design and rationale of the Cl ...... rative Studies Program no. 424
@nl
P2093
P1476
Design and rationale of the Cl ...... rative Studies Program no. 424
@en
P2093
Bernard R Chaitman
Crystal L Harris
Daniel S Berman
David J Maron
G B John Mancini
Koon K Teo
Leslee Shaw
Marcin Dada
Merril Knudtson
Pamela M Hartigan
P304
P356
10.1016/J.AHJ.2005.08.015
P407
P577
2006-06-01T00:00:00Z